Treatment of Hypoparathyroidism with Symptomatic Hypocalcaemia and Low Ionised Calcium (< 1.00 mmol/L)
Clinical scenario
This protocol addresses patients with hypoparathyroidism who present with active symptoms of hypocalcaemia together with an albumin-adjusted calcium level below 2.0 mmol/L (< 8.0 mg/dL), or an ionised calcium below 1.00 mmol/L — a threshold at which intervention is indicated.
Why this situation requires treatment
Current guidelines recommend treatment of all patients with chronic hypoparathyroidism who have symptoms of hypocalcaemia and/or an albumin-adjusted calcium below 2.0 mmol/L, which corresponds to an ionised calcium below 1.00 mmol/L. The coexistence of both symptomatic and biochemical criteria marks a clinically significant hypocalcaemic state.
Treatment approach — partial overview
When hypocalcaemia is life-threatening, the immediate step is urgent intravenous calcium replacement. Once the acute phase is managed, therapy transitions to oral calcium supplementation combined with an activated form of vitamin D. The complete protocol — including the exact sequence, agent selection, infusion approach, and monitoring requirements — is accessible via the link below.
References
DOI: 10.1093/ejendo/lvaf222
We recommend treatment of all patients with chronic HypoPT who have symptoms of hypocalcaemia and/or an albumin-adjusted calcium level < 2.0 mmol/L (< 8.0 mg/dL) ≈ ionised calcium (iCa2+) < 1.00 mmol/L.
In a life-threatening hypocalcaemia emergency, 90-180 mg elemental calcium, e.g., preferably 1-2 ampules calcium gluconate (containing 1 g calcium gluconate per ampule) is administered over 10 to 20 minutes, followed by a slower intravenous calcium infusion, e.g., 10 ampules containing about 900 mg elemental calcium into 1 litre of 5% dextrose or saline at a starting rate of 100 ml/h.
In addition to close monitoring of calcium levels and ECG, oral therapy with calcium supplements and activated vitamin D (e.g., calcitriol 0.25 or 0.5 µg twice daily) should be started.
View source ↗